1. Prospective therapeutics for intestinal and hepatic fibrosis
   Xin Li et al, 2023, Bioengineering & Translational Medicine CrossRef
2. Negative regulation of PI3K/AKT/mTOR axis regulates fibroblast proliferation, apoptosis and autophagy play a vital role in triptolide-induced epidural fibrosis reduction
   Jihang Dai et al, 2019, European Journal of Pharmacology CrossRef
3. Herbs-Partitioned Moxibustion Combined with Acupuncture Inhibits TGF-β1-Smad-Snail-Induced Intestinal Epithelial Mesenchymal Transition in Crohn’s Disease Model Rats
   Yin Shi et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
4. Prevention and Treatment of Stricturing Crohn’s Disease – Perspectives and Challenges
   Joseph Sleiman et al, 2021, Expert Review of Gastroenterology & Hepatology CrossRef
5. Progress in active compounds effective on ulcerative colitis from Chinese medicines
   Si-Yu CAO et al, 2019, Chinese Journal of Natural Medicines CrossRef
6. Triptolide attenuates irritable bowel syndrome via inhibiting ODC1
   Ning Zhu et al, 2023, BMC Gastroenterology CrossRef
7. Interleukin 6 inhibition by triptolide prevents inflammation in a mouse model of ulcerative colitis
   Haifeng Zhang et al, 2017, Experimental and Therapeutic Medicine CrossRef
8. Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases—A Review
   Kai Yuan et al, 2019, Frontiers in Pharmacology CrossRef